Report Description

Label-free Array Systems Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing demand for personalized medicines, rapid drug delivery, biomarker identification, identification of specific protein marker in specific disease or condition and increased usage of Label-free Array Systems Market as a research tool in drug discovery.

Without the use of fluorescent or radioactive labels, label-free array systems are analytical tools, which are utilized to identify and quantify biomolecules in complicated samples. These devices work on the concept of  Surface Plasmon Resonance (SPR), which enables measurement of biomolecule binding to the array surface as well as changes in the reflected light.

Moreover, Label-free array systems are advantageous as there is no need for the  use of hazardous or costly labelling agents, which makes them a safer and more affordable substitute compared to conventional labelling techniques. Label-free array devices can be used to analyze biomolecule interactions in real time without the use of fluorescence or radioactivity, providing dynamic and quantitative data about the interacting molecules.

Increasing Demand for Personalized Medicine

In recent times, modern medicines are gradually moving towards precision medicine to eliminate the individuals dose dismissal. Label-free array systems eliminate the requirement for dyes, reagents, modified cells, and tags while providing data that is extremely sensitive for an endogenous target in live cell experiments. Techniques such as Interference-based Surface Plasmon Resonance (SPR), Scanning Kelvin Nanoprobe, Atomic Force Microscopy, etc. are utilized in label-free detection. Furthermore, installing even a few of the thousands of potential diagnostic biomarkers identified each year as part of personalized treatment workflows, necessitates clinically efficient biosensor technologies to monitor multiple biomarkers in patients in real time. In this way label-free array system is of great importance and is thereby adding to support the market growth driving personalized medicine demand.

Growing Demand of Label-Free Array Systems in Biomedical System

The growing demand of label-free array system is highly observed in biomedical medicines along with biological sciences. Advancement and update in science, nanotechnology, and integrated computational configuration is promoting the development of label-free array systems such as microarrays, label-free biosensor arrays, etc. These microarray, label-free biosensor techniques are helpful in getting efficient clarity of- disease signaling pathway, biomarker screening, drug discovery, protein profiling, drug target identification, etc. and is therefore aiding the diagnostic process which is further adding to the market demand by propelling the market growth. Also, Manufacturers are focusing on developing efficient and accurate readout-systems and cellular models with respect to launching mechanisms and functional studies on cellular and molecular level.

Rising Focus on Drug Delivery Efficiency

Based on the Label-Free Array Systems and patient samples, the leading market players are generating biorelevant data, which further helps in improved drug development. The Label-free methods, like detection and measurement of a local change in refractive index, are utilized for studying distinct interactions, comprising  Leading market players are producing biorelevant data using Label-Free Array Systems and patient samples, which further aids in improved medication development drug molecules and their receptors. For instance, Mass Spectroscopy is utilized as a label-free approach to drug delivery. For Instance, scientists from Merck, matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to peptides to identify their absorption, distribution, metabolism, and excretion (ADME) properties, thereby increasing the market growth with the rise in utilization for drug delivery practices.

Growing demand of Atomic Force Spectroscopy

Atomic Force Microscopy (AFM) is high in demand due to its advanced applications, including  diagnosis and carrying cancer research. The applications of AFM to carry crucial operations on cells moreover in physiological set ups, help in the study of the mechanical characteristics of the living cells. Also, Atomic Force Microscopy (AFM) includes the involvement of minimum sample manipulation and is therefore an efficient tool for research and study of biological materials such as bacteria, DNA, cells, and viruses in their native environments. Hence, the market demand for label-free array systems is enhanced by the utilization of AFM to be employed as a high-resolution research tool to examine and identify the mechanical properties and ultrastructure of tumor cells.


Download Free Sample Report

Market Segmentation

Label-free Array Systems Market is segmented based on the type, application, end user, and region. Based on type, the market is segmented into surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others. Based on application, the market is segmented into drug discovery, protein interface analysis, antibody characterization, and others. Based on end users, the market is further fragmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations and others. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG, etc.., are some of the major players operating in the Global Label-free Array Systems Market.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Type

Mode

Application

End User

Regional Scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait

Key Companies Profiled

Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Global Label-free Array Systems Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Label-free Array Systems Market, By Type:
    • Surface Plasmon Resonance
    • Bio-layer Interferometry
    • Cellular Dielectric Spectroscopy
    • Others
  • Label-free Array Systems Market, By Mode:
    • Automated ELISA Analyzers
    • Semi-Automated Analyzers
  • Label-free Array Systems Market, By Application:
    • Drug Discovery
    • Protein Interface Analysis
    • Antibody Characterization
    • Others
  • Label-free Array Systems Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institute
    • Contract Research Organization
    • Others
  • Label-free Array Systems Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Label-free Array Systems Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Global Label-free Array Systems Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered.

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Label-free Array Systems Market Outlook.

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others)

5.2.2.    By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others)

5.2.3.    By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others)

5.2.4.    By Company (2022)

5.2.5.    By Region

5.3.  Product Market Map

6.    Asia-Pacific Global Label-free Array Systems Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    Type

6.2.2.    Application

6.2.3.    End user

6.2.4.    By Country

6.3.  Asia-Pacific: Country Analysis

6.3.1.    China Global Label-free Array Systems Market Outlook.

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           Type

6.3.1.2.2.           Application

6.3.1.2.3.           End user

6.3.2.    India Global Label-free Array Systems Market Outlook.

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           Type

6.3.2.2.2.           Application

6.3.2.2.3.           End user

6.3.3.    South Korea Global Label-free Array Systems Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           Type

6.3.3.2.2.           Application

6.3.3.2.3.           End user

6.3.4.    Japan Global Label-free Array Systems Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           Type

6.3.4.2.2.           Application

6.3.4.2.3.           End user

6.3.5.    Australia Global Label-free Array Systems Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           Type

6.3.5.2.2.           Application

6.3.5.2.3.           End user

7.    Europe Global Label-free Array Systems Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    Type

7.2.2.    Application

7.2.3.    End user

7.2.4.    By Country

7.3.  Europe: Country Analysis

7.3.1.    France Global Label-free Array Systems Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           Type

7.3.1.2.2.           Application

7.3.1.2.3.           End user

7.3.2.    Germany Global Label-free Array Systems Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           Type

7.3.2.2.2.           Application

7.3.2.2.3.           End user

7.3.3.    United Kingdom Global Label-free Array Systems Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           Type

7.3.3.2.2.           Application

7.3.3.2.3.           End user

7.3.4.    Italy Global Label-free Array Systems Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           Type

7.3.4.2.2.           Application

7.3.4.2.3.           End user

7.3.5.    Spain Global Label-free Array Systems Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           Type

7.3.5.2.2.           Application

7.3.5.2.3.           End user

8.    North America Humic-based bio stimulants Market Outlook.

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    Type

8.2.2.    Application

8.2.3.    End user

8.2.4.    By Country

8.3.  North America: Country Analysis

8.3.1.    United States Global Label-free Array Systems Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           Type

8.3.1.2.2.           Application

8.3.1.2.3.           End user

8.3.2.    Mexico Global Label-free Array Systems Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           Type

8.3.2.2.2.           Application

8.3.2.2.3.           End user

8.3.3.    Canada Global Label-free Array Systems Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           Type

8.3.3.2.2.           Application

8.3.3.2.3.           End user

9.    South America Global Label-free Array Systems Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    Type

9.2.2.    Application

9.2.3.    End user

9.2.4.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Global Label-free Array Systems Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           Type

9.3.1.2.2.           Application

9.3.1.2.3.           End user

9.3.2.    Argentina Global Label-free Array Systems Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           Type

9.3.2.2.2.           Application

9.3.2.2.3.           End user

9.3.3.    Colombia Global Label-free Array Systems Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           Type

9.3.3.2.2.           Application

9.3.3.2.3.           End user

10. Middle East and Africa Global Label-free Array Systems Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. Type

10.2.2. Application

10.2.3. End user

10.2.4. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Global Label-free Array Systems Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         Type

10.3.1.2.2.         Application

10.3.1.2.3.         End user

10.3.2. Saudi Arabia Global Label-free Array Systems Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         Type

10.3.2.2.2.         Application

10.3.2.2.3.         End user

10.3.3. UAE Global Label-free Array Systems Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         Type

10.3.3.2.2.         Application

10.3.3.2.3.         End user

10.3.4. Kuwait Global Label-free Array Systems Market Outlook

10.3.4.1.     Market Size & Forecast

10.3.4.1.1.         By Value

10.3.4.2.     Market Share & Forecast

10.3.4.2.1.         Type

10.3.4.2.2.         Application

10.3.4.2.3.         End user

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Developments

12.2.             Mergers & Acquisitions

12.3.             Product Developments

13. Competitive Landscape

13.1.             Business Overview

13.2.             Company Snapshot

13.3.             Products & Services

13.4.             Financials (In case of listed companies)

13.5.             Recent Developments

13.6.             SWOT Analysis

13.6.1. Illumina, Inc.

13.6.2. Thermo Fisher Scientific, Inc.

13.6.3. Agilent Technologies, Inc.

13.6.4. PerkinElmer, Inc.

13.6.5. Merck KGaA

13.6.6. Danaher Corporation

13.6.7. Bio-Rad Laboratories, Inc.

13.6.8. F. Hoffmann-La Roche AG

13.6.9. Becton, Dickinson and Company

13.6.10. Sartorius AG

14. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The limit of detection and sensitivity of the device are some of the key factors hampering the growth of Global Label-free Array Systems Market in the forecast period.

down-arrow

Growing demand for personalized medicine, increasing research & development in the biomedical sciences, growing utilization of atomic force spectroscopy are factors driving the growth of the Global Label-free Array Systems Market in the forecast years, 2024-2028.

down-arrow

Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG. etc. are some of the leading companies functioning in the Global Label-free Array Systems Market in the forecast period, 2024-2028.

down-arrow

North America is estimated to dominate the Global Label-free Array Systems Market on account of increased research and Leading market players are producing biorelevant data using Label-Free Array Systems and patient samples, which further aids in improved medication development. development in the pharmaceutical and biotechnological companies along with a high number of leading companies performing in cell-based research in the region.

profile

Sakshi Bajaal

Business Consultant
Press Release

Label-Free Array Systems Market To Be Dominated By The Drug Discovery Segment By 2028

May, 2023

Technological advancement for diagnostics is expected to drive Global Label-Free Array Systems Market in the forecast period, 2024-2028.